| Description |
xvii, 446 pages : illustrations ; 26 cm |
|
regular print |
| Contents |
Note continued: 14.2.Nursing Homes -- 14.2.1.Personnel to Meet the Demands -- 14.2.2.Palliative Care Services -- 14.2.3.Palliative Care Education -- 14.2.4.Regulations -- 14.2.5.Cognitive Impairment -- 14.3.Advance Directives -- 14.3.1.Historical Evolution -- 14.3.2.Usefulness of Advance Directives -- 14.4.Artificial Nutrition -- 14.4.1.Enteral Nutrition History -- 14.4.2.Enteral Nutrition Use -- 14.5.Practical Guidelines for Alternatives to Artificial Nutrition -- Key Features of Nursing Homes -- Ethical Issues -- Summary Points -- Acknowledgments -- List of Abbreviations -- References -- ch. 15 Support for Hydration at End-of-Life / Robin L. Fainsinger -- 15.1.Introduction -- 15.2.Background to the Hydration Controversy -- 15.3.Clarifying Terminology -- 15.4.Hydration Research -- 15.5.Social, Cultural, and Ethical Issues -- 15.6.Options for Alternative Hydration -- 15.6.1.Nasogastric Tubes and Gastrostomy -- 15.6.2.Hypodermoclysis -- 15.6.3.Rectal Hydration -- Key Points -- Summary Points -- References -- ch. 16 Palliative Treatment of Dysphagia / Christian Selinger -- 16.1.Introduction -- 16.2.Pathophysiology and Anatomy of Dysphagia -- 16.2.1.Neuromuscular Dysphagia -- 16.2.2.Dysphagia by Oral, Head and Neck Cancers -- 16.2.2.1.Oesophageal and High Gastric Obstruction -- 16.2.2.2.Gastric Outlet Obstruction -- 16.3.Applications to Other Areas of Terminal or Palliative Care -- 16.4.Practical Procedures and Techniques -- 16.4.1.Nasogastric Tube (NG) Insertion -- 16.4.2.Endoscopically Placed Feeding Tubes -- 16.4.3.Radiologically Induced Gastrostomy -- 16.4.4.Stents -- 16.4.5.Surgically Placed Feeding Tubes -- 16.4.6.Surgical Bypass Procedures -- 16.5.Evidence for Dysphagia Treatment According to Indication -- 16.5.1.Neurological and Muscular Disorders -- 16.5.1.1.Stroke Disease -- 16.5.1.2.Motor-Neuron Disease -- 16.5.1.3.Dementia -- 16.5.2.Other Neuromuscular Diseases -- 16.6.Head and Neck Tumours -- 16.6.1.Oesophageal and High Gastric Obstruction -- 16.6.2.Gastric Outlet Obstruction -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 17 Fatigue in Hospice Cancer Patients: How Do Nutritional Factors Contribute? / Shiow-Ching Shun -- 17.1.Introduction -- 17.2.Definition of Cancer-Related Fatigue (CRF) -- 17.3.Pathophysiology of Fatigue -- 17.4.Malnutrition and Cancer-Related Fatigue in Terminal Patients -- 17.4.1.Malnutrition, Cachexia, and Fatigue -- 17.4.2.Malnutrition Related to Anorexia, Treatments, and Cancer -- 17.5.Cancer-Related Symptoms Directly Influencing Food Intake and Fatigue -- 17.5.1.Head and Neck Cancer-Related Problems -- 17.5.2.Gastrointestinal System-Related Problems and Malnutrition -- 17.6.Common Physical Symptoms Related to Food Intake and Fatigue -- 17.7.Psychological Distress, Fatigue, and Malnutrition -- 17.8.Managing Cancer-Related Fatigue in Terminal Cancer Patients: Integrating Nutrition-Related Factors -- Ethical Issues -- Summary Points -- List of Abbreviation -- References -- ch. 18 Taste Alteration in Palliative Care / Michio Sata -- 18.1.Introduction -- 18.2.Types of Taste Alterations -- 18.2.1.Assessments of Taste Alteration -- 18.2.2.Mechanisms of Taste Alteration -- 18.3.Practical Methods and Techniques -- 18.3.1.Modification of Food -- 18.3.1.1.Flavors -- 18.3.1.2.Palatability -- 18.3.2.Agents -- 18.3.2.1.Sialogogues -- 18.3.2.2.Saliva substitutes -- 18.3.3.Nutrients -- 18.3.3.1.Zinc -- 18.3.3.2.BCAA -- 18.4.Conclusion -- Summary Points -- Acknowledgments -- List of Abbreviation -- References -- ch. 19 Olfaction in Palliative Care Patients / Yoav P. Talmi -- 19.1.Introduction -- 19.2.Biology of Olfaction -- 19.3.Causes of Impaired Olfaction -- 19.4.Practical Methods and Techniques -- Summary Points -- References -- ch. 20 Withholding or Withdrawing Nutritional Support at the End-of-Life in Six European Countries / Agnes van der Heide -- 20.1.Introduction -- 20.2.Nation-Wide Death Certificate Studies -- 20.2.1.Frequencies of Withholding or Withdrawing ANH in Six West European Countries -- 20.2.2.Characteristics of Patients in Whom ANH was Forgone in Six West European Countries -- 20.3.Communication About Withholding or Withdrawing ANH -- 20.4.Withholding or Withdrawing ANH in Combination with Possibly Life-Shortening Drugs to Relieve Symptoms -- 20.5.International Differences -- 20.6.Applications to Other Areas of Terminal or Palliative Care -- 20.7.Guidelines -- Key Facts in How to Distinguish Forgoing Artificial Nutrition or Hydration from Other Medical End-of-Life Decisions -- Ethical Issues -- Summary Points -- Acknowledgments -- List of Abbreviations -- References -- Section IV Cancer -- ch. 21 The Concept of Cachexia-Related Suffering (CRS) in Palliative Cancer Care / F. Strasser -- 21.1.Introduction -- 21.2.Malnutrition -- 21.3.Cachexia-Related Suffering (CRS) -- 21.3.1.Prevalence of CRS -- 21.3.2.Characteristics of CRS -- 21.3.2.1.Presentation of CRS -- 21.3.2.2.Mechanisms Leading to CRS -- 21.3.3.Reactions to CRS -- 21.3.3.1.Constructive Reactions -- 21.3.3.2.Adverse Reactions -- 21.3.4.Assessment of CRS -- 21.4.Applications to Other Areas of Terminal or Palliative Care -- 21.5.Practical Methods and Techniques -- Key Points -- Ethical Issues -- Summary Points -- Acknowledgments -- List of Abbreviations -- References -- ch. 22 An Overview of Gastrointestinal Side Effects in Tumour Therapy: Implications for Nutrition / Frank Mayer -- 22.1.Introduction -- 22.2.Nausea and Vomiting -- 22.2.1.Pharmacological Therapy of Nausea and Vomiting -- 22.2.2.Nutritional Impact of Nausea and Vomiting -- 22.2.2.1.General Aspects -- 22.2.2.2.Ginger to Prevent or Reduce Emesis -- 22.3.Mucositis -- 22.3.1.Prevention and Therapy of Mucositis -- 22.3.2.Nutritional Impact of Mucositis -- 22.4.Diarrhoea -- 22.4.1.Assessment and Early Intervention -- 22.4.2.Nutritional Impact of Diarrhoea -- 22.4.2.1.Glutamine for Protection of the Intestinal Mucosa -- 22.4.2.2.Probiotics for Prevention of Diarrhoea -- 22.5.Constipation -- 22.5.1.Pharmacological Therapy of Constipation -- 22.5.2.Managing Constipation -- 22.5.3.Nutritional Impact of Constipation -- 22.6.Changes in Perception of Taste and Smell -- Key Facts of Malnutrition -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 23 Nutritional Status and Relationship to Upper Gastrointestinal Symptoms in Patients with Advanced Cancer Receiving Palliative Care / Tiziana Sappia -- 23.1.Introduction -- 23.1.1.Malnutrition: Causes and Consequences -- 23.2.Application to Other Areas of Palliative Care -- 23.3.Practical Procedures and Techniques -- 23.3.1.Case History -- 23.3.2.Dietary Records -- 23.3.3.Physical Examination -- 23.3.4.Anthropometric Assessment -- 23.3.4.1.Body Weight -- 23.3.4.2.Body Height -- 23.3.4.3.Circumferences -- 23.3.5.Laboratory Analysis -- 23.3.5.1.Plasma Proteins -- 23.3.5.2.Laboratory Analysis to Assess Muscle Mass -- 23.3.5.3.Nitrogen Balance -- 23.3.5.4.Immunological Tests -- 23.3.5.5.Functional Tests -- 23.3.6.Nutritional Screening Tools -- 23.3.7.Human Body Composition -- 23.3.7.1.Body Composition Measurement Techniques -- 23.4.Aspects of Nutritional Status in Palliative Care -- 23.5.Relationship between Nutritional Status and Upper Gastrointestinal Symptoms -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 24 Nutrition and Palliative Surgery for Head and Neck Cancer / Ryuichi Hayashi -- 24.1.Introduction -- 24.1.1.Advanced Head and Neck Cancer -- 24.1.2.Nutrition and Quality of Life -- 24.2.Applications in Other Areas of Terminal or Palliative Care -- 24.3.Practical Methods and Techniques -- 24.3.1.Palliative Surgery -- 24.3.2.Complications and Hospitalization -- 24.3.3.Case 1 -- 24.3.4.Case 2 -- 24.3.5.Indication -- Key Facts of Head and Neck Cancer -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch |
|
25 Total Parenteral Nutrition for Patients with Advanced, Life-Limiting Cancer: Clinical Context, Potential Risks and Benefits, and a Suggested Approach / Jane L. Wheeler -- 25.1.Introduction -- 25.2.Metabolic Changes in the Patient with Advanced Cancer -- 25.3.Cancer Anorexia-Cachexia Syndrome -- 25.4.Total Parenteral Nutrition -- 25.5.Clinical Risks Associated with TPN -- 25.6.Potential Negative Effects of TPN -- 25.7.Potential Positive Effects of TPN -- 25.8.Applications to Other Areas of Terminal or Palliative Care -- 25.9.Guidelines for Clinical Practice -- 25.9.1.Guidelines for Patients with Advanced Cancer -- 25.9.2.Additional Factors Influencing the Palliative Use of TPN -- 25.9.3.TPN: A Pragmatic Clinical Approach -- Key Points to Communicate to Patients and Their Families -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 26 Vitamin Deficiency in Patients with Terminal Cancer / Dominic J. Harrington -- 26.1.Introduction -- 26.1.1.Challenges Faced by Patients with Terminal Cancer -- 26.2.Fat-Soluble Vitamins -- 26.2.1.Vitamin A -- 26.2.2.Vitamin D -- 26.2.3.Vitamin E -- 26.2.4.Vitamin K -- 26.3.Water-Soluble Vitamins -- 26.3.1.Vitamin C (Ascorbic Acid) -- 26.3.2.Folate (Vitamin B9) -- 26.3.3.Vitamin B12 -- 26.3.4.Vitamin B6 -- 26.3.5.Thiamine (Vitamin B1) -- 26.3.6.Riboflavin (Vitamin B2) -- 26.3.7.Niacin (Vitamin B3) -- 26.3.8.Biotin (Vitamin B7) -- 26.3.9.Pantothenic Acid (Vitamin B5) -- 26.4.Practical Methods and Techniques -- 26.4.1.Fat-Soluble Vitamins -- 26.4.1.1.Vitamin A -- 26.4.1.2.Vitamin D -- 26.4.1.3.Vitamin E -- 26.4.1.4.Vitamin K -- 26.4.2.Water-Soluble Vitamins -- 26.4.2.1.Vitamin C -- 26.4.2.2.Folate -- 26.4.2.3.Vitamin B12 -- 26.4.2.4.Vitamin B6 -- 26.4.2.5.Thiamine (Vitamin B1) -- 26.4.2.6.Riboflavin (Vitamin B2) -- 26.4.2.7.Niacin (Vitamin B3) -- 26.4.2.8.Biotin (Vitamin B7) -- 26.4.2.9.Pantothenic Acid (Vitamin B5) -- Key Facts: Vitamin Deficiency in Patients with Terminal Cancer -- Summary Points -- Acknowledgments -- List of Abbreviations -- References -- |
|
Note continued: ch. 27 Position of Appetite and Nausea in Symptom Clusters in Palliative Radiation Therapy / Edward Chow -- 27.1.Introduction -- 27.2.Key Features of Symptom Clusters -- 27.2.1.What Are They? -- 27.2.2.Why Are They Useful? -- 27.3.Tools Used in Symptom Cluster Research -- 27.4.Radiation-Induced Nausea/Vomiting -- 27.5.Nausea/Vomiting and Appetite in Symptom Clusters in Bone Metastases -- 27.6.Nausea/Vomiting and Appetite in Symptom Clusters in Brain Metastases -- 27.6.1.Studies Conducted -- 27.6.2.Study Conclusions -- 27.7.Applications to Other Areas of Palliative Care -- 27.8.Guidelines -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 28 Palliative Gastrojejunostomy and the Impact on Nutrition in Cancer / Jeffrey M. Farma -- 28.1.Introduction -- 28.1.1.Acute Presentation of GOO -- 28.1.2.Clinical Presentation -- 28.1.3.Diagnostic Evaluation -- 28.2.Nutritional Complications of GOO -- 28.2.1.Proximal GOO -- 28.2.2.Duodenal and Biliary Obstruction -- 28.2.3.Pancreatic Duct Obstruction -- 28.2.4.Nutritional Deficiencies -- 28.3.Surgical Techniques -- 28.3.1.Gastrojejunostomy -- 28.3.2.Risks Associated with Gastrojejunostomy -- 28.3.3.Partial Stomach-Partitioning Gastrojejunostomy -- 28.3.4.Role of Prophylactic Gastrojejunostomy -- 28.4.Biliary Obstruction -- 28.5.Minimally Invasive Surgical Techniques -- 28.6.Non-Surgical Options -- 28.7.Guidelines -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- Section V Other Conditions -- ch. 29 Nutritional Support in the Vegetative State: Artificial Nutrition and Hydration in the Limbo between Life and Death / Giuseppe Nattino -- 29.1.Introduction -- 29.1.1.The Vegetative State -- 29.1.2.Nutrition in PVS Patients -- 29.2.Applications to Other Areas of Terminal or Palliative Care -- 29.3.Practical Methods and Techniques -- 29.3.1.Energy Expenditure -- 29.3.2.Nutritional Requirements in PVS Patients -- 29.3.3.Enteral Feeding Routes and Techniques -- 29.3.4.Complications and Their Prevention -- 29.3.4.1.Constipation, Impaired Gastrointestinal Motility, and Diarrhea -- 29.3.4.2.Tube Occlusion -- 29.3.4.3.Accidental Tube Removal -- 29.3.4.4.Gastric Sores Due to the Internal Portion of the Tube -- 29.3.4.5.Intestinal Occlusion by Tube Dragging -- 29.4.Ethical Issues -- 29.4.1.Artificial Nutrition and Hydration (ANH): Medical Treatment or Loving Care? -- 29.4.2.Withdrawing ANH -- 29.4.3.Ethical Principles Informing the Decision -- Summary Points -- List of Abbreviations -- References -- ch. 30 Nutrition and Appetite Regulation in Children and Adolescents with End-Stage Renal Failure / Jorg Dotsch -- 30.1.Introduction -- 30.2.Appetite Regulation -- 30.2.1.Normal Appetite Regulation -- 30.2.2.Dysregulation of Appetite in End-Stage Renal Disease -- 30.2.2.1.Leptin and Ghrelin -- 30.2.2.2.Uremia -- 30.3.Protein Energy Wasting -- 30.3.1.Inflammation -- 30.3.2.Dialysate Nutrient Losses -- 30.3.3.Metabolic Acidosis -- 30.3.4.Endocrine Disorders and Concomitant Diseases -- 30.4.Nutrition and Diet -- 30.4.1.General Aspects of Nutrition and Diet in End-Stage Renal Failure -- 30.4.1.1.Calories, Protein, and Body Weight -- 30.4.1.2.Sodium and Fluids -- 30.4.1.3.Phosphorus and Calcium -- 30.4.1.4.Potassium -- 30.4.1.5.Vitamins and Minerals -- 30.4.2.Infants -- 30.4.3.Children -- 30.4.4.Adolescents -- 30.4.5.Adults -- 30.5.Application to Other Areas of Terminal or Palliative Care -- 30.6.Practical Methods and Techniques -- Key Facts of Renal Failure -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 31 Nutrition in End-Stage Liver Disease / Valentina Medici -- 31.1.Introduction -- 31.2.Pathophysiology of Malnutrition in End-Stage Liver Disease -- 31.3.Specific Nutrient Deficiencies in End-Stage Liver Disease and Associated Clinical Features -- 31.3.1.Protein Calorie Malnutrition -- 31.3.2.Vitamins -- 31.3.3.Minerals -- 31.4.Evaluation of Nutritional Status in End-Stage Liver Disease -- 31.5.Treatment -- 31.6.Applications to Other Areas of Terminal or Palliative Care -- 31.7.Practical Methods and Techniques -- Key Points of Malnutrition in End-Stage Liver Disease -- Ethical Issues -- Summary Points -- List of Abbreviation -- References -- ch. 32 Nutritional Therapy in Amyotrophic Lateral Sclerosis / Susanne Petri -- 32.1.Introduction -- 32.2.Nutrition Principles in ALS -- 32.3.Management of Dysphagia -- 32.4.Enteral Nutrition in ALS -- 32.4.1.Nasogastric Tube in ALS -- 32.4.2.Percutaneous Endoscopic Gastrostomy in ALS -- 32.4.2.1.Timing of PEG Tube Placement -- 32.4.2.2.PEG and Aspiration -- 32.4.3.Percutaneous Radiologic Gastrostomy/Radiologically Inserted Gastrostomy -- 32.5.Home Parenteral Nutrition in ALS -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 33 Nutritional Considerations of Palliative Care in Rare Disease: The Motor Disorder Disease Achalasia / Fabio Cisaro -- 33.1.Introduction -- 33.2.Pathophysiology -- 33.3.Clinical Picture and Diagnosis -- 33.4.Treatment Options -- 33.4.1.Pharmacologic Treatments -- 33.4.2.Endoscopic Procedures -- 33.4.3.Surgical Treatment -- 33.5.Applications to Other Areas of Palliative Care -- 33.6.Guidelines and Practical Methods and Techniques -- 33.7.Nutritional Aspects of Achalasia -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- Section VI Pharmacological Aspects -- ch. 34 Steroid-Induced Side Effects Affecting Diet and Nutrition in Palliative Care: Oral Candidiasis and Other Conditions / Jana Pilkey -- 34.1.Introduction -- 34.2.Oral and Esophageal Candidiasis -- 34.3.Risk Factors -- 34.4.Practical Methods and Techniques -- 34.4.1.Diagnosis -- 34.4.2.Treatment -- 34.4.3.Ethical Issues -- 34.5.Gastritis and Gastroduodenal Ulceration -- 34.5.1.Incidence -- 34.5.2.Risk Factors -- 34.6.Practical Methods and Techniques -- 34.6.1.Prophylaxis and Treatment -- 34.6.2.Ethical Issues -- 34.7.Impaired Glucose Metabolism -- 34.7.1.Monitoring -- 34.7.2.Practical Methods and Techniques -- 34.7.2.1.Oral Agents -- 34.7.2.2.Insulin -- 34.7.3.Ethics and Diabetic Management in the Dying -- 34.7.4.Hiccups -- 34.8.Applications to Other Areas of Palliative Care -- Summary Points -- Acknowledgments -- List of Abbreviations -- References -- ch. 35 Appetite Stimulant Use in the Palliative Care of Cystic Fibrosis / Darcie D. Streetman -- 35.1.Introduction -- 35.2.Appetite Stimulants -- 35.2.1.Megestrol Acetate (MA) -- 35.2.2.Cyproheptadine Hydrochloride (CH) -- 35.2.3.Dronobinal (Marinol®) -- 35.2.4.Antipsychotic/Antidepressant Agents -- 35.2.4.1.Antipsychotic Drugs -- 35.2.4.2.Antidepressants -- 35.2.5.Recombinant Human Growth Hormone (rhGH) -- 35.2.6.Anabolic Androgenic Steroids (AAS) -- 35.3.Applications to Other Areas of Terminal or Palliative Care -- Ethical Issues -- Summary Points -- List of Abbreviations -- References -- ch. 36 Warfarin -- Nutrition Interactions in the Hospice and Palliative Care Setting / Jeffrey L. Spiess -- 36.1.Introduction -- 36.2.The Coagulation Cascade -- 36.3.Vitamin K Antagonists -- 36.4.Warfarin in Clinical Practice -- 36.5.Warfarin Indications and Cautions -- 36.6.Vitamin K -- 36.7.Vitamin K as a Therapeutic Agent -- 36.8.Non-Vitamin K Warfarin-Nutrition Interactions -- 36.9.Application to Other Areas of Terminal or Palliative Care -- 36.10.Guidelines -- Ethical Issues -- Summary Points -- Acknowledgments -- List of Abbreviations -- References |
| Notes |
Formerly CIP. Uk |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Donated by Mrs Erica Diment for the Library Bookplate appeal 2008 Mrs Erica Diment |
| Subject |
Diet therapy.
|
|
Nursing.
|
|
Palliative treatment.
|
|
Terminal care.
|
|
Terminally ill -- Nutrition.
|
|
Palliative Care.
|
|
Nutrition Therapy.
|
|
Terminal Care.
|
|
Diet Therapy.
|
|
Nutrition
|
|
Palliative Care.
|
| Author |
Preedy, Victor R.
|
| ISBN |
1439819327 (hbk.) |
|
9781439819326 (hbk.) |
|
